Nanomaterial-based glucose sensors: detection platforms and highlight applications
Аннотация
Glucose acts as a fundamental energy substrate sustaining human physiological homeostasis, and aberrant blood glucose levels are tightly correlated with a spectrum of metabolic disorders, particularly diabetes mellitus, which has evolved into a severe global public health crisis. Precise, rapid, and stable glucose monitoring is therefore indispensable for the early diagnosis, clinical intervention, and long-term management of diabetes. Conventional enzyme-dependent glucose sensors suffer from inherent limitations, including high manufacturing costs, inferior environmental stability, short service lifespan, and susceptibility to fluctuations in pH and temperature, which substantially constrain their practical clinical and industrial applications. Benefiting from their unique structural tunability and superior physicochemical properties, nanomaterial-based glucose sensing platforms have emerged as high-performance alternatives to traditional enzymatic sensors, achieving remarkable advancements in detection sensitivity, selectivity, and operational stability, while enabling continuous and non-invasive glucose monitoring. This comprehensive review systematically elaborates the state-of-the-art progress of nanomaterial-enabled glucose sensing technologies, focusing on two dominant detection modalities: electrochemical and optical sensing strategies. We emphatically discuss the rational design of functional nanomaterials, innovative construction of multicomponent nanocomposites, development of flexible wearable sensing systems, and emerging signal transduction mechanisms. Meanwhile, this review comprehensively categorizes and evaluates the performance characteristics and application progress of diverse nanomaterial-based glucose sensors, covering precious/non-precious metal nanomaterials, metal–organic frameworks, carbon-based materials, multifunctional nanocomposites, and molecularly imprinted polymer (MIP)-integrated sensing platforms. Furthermore, we thoroughly analyze the current commercialization landscape of continuous and non-invasive glucose monitoring devices. Finally, the core challenges hindering the clinical translation and large-scale commercialization of high-performance glucose sensors are highlighted, and targeted future research directions and development prospects are prospected, aiming to provide insightful theoretical guidance and technical references for the design and optimization of next-generation clinical glucose sensing technologies. Graphic abstract